Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Interim Results

27 Sep 2005 12:09

Azure Holdings Plc (" Company") Interim results for the six months ended 30 June 2005 Chairman's statementIn the six months ended 30 June 2005 the Company incurred a loss before andafter taxation of ‚£74,000 (2004: ‚£229,000).Because of the lack of cash in the Company, creditors have increased butcontinue to be supportive.The directors are continuing to keep overheads to a minimum, the expenses beingthose necessary to maintain the Company's listing on AIM.The board continues to seek an acquisition for the Company.Owing to a technicality, the Company no longer has any authority to issue anyof its share capital and will therefore be convening an extraordinary generalmeeting for this purpose.Nicolas GreenstoneChairman27 September 2005Azure Holdings plcProfit and Loss Accountfor the six months ended 30 June 2005 6 months 6 months Year ended ended 30 ended 30 31 December June 2004 2004 June 2005 (unaudited) (audited) (unaudited) ‚£'000 ‚£'000 ‚£'000 Turnover - - - Administrative expenses (74) (229) (345) Operating loss (74) (229) (345) Loss on ordinary activities before (74) (229) (345)taxation Tax on loss on ordinary activities - - - Loss on ordinary activities after (74) (229) (345)taxation Retained loss for the period (74) (229) (345) Loss per ordinary share (0.15p) (0.65p) (0.86p) The profit and loss account has been prepared on the basis that all operationsare continuing operations. All recognised gains or losses are dealt withthrough the profit and loss account or statement of recognised gains andlosses.Azure Holdings plcBalance Sheetas at 30 June 2005 30 June 2005 30 June 31 December 2004 2004 (unaudited) (unaudited) (audited) ‚£'000 ‚£'000 ‚£'000 Current assets Debtors 3 14 7 Cash at bank and in hand 1 10 14 4 24 21 Creditors: amounts falling due within one (147) (81) (90)year Net current liabilities (143) (57) (69) Total assets less current liabilities (143) (57) (69) Net liabilities (143) (57) (69) Capital and reserves Called up Share Capital 5,475 5,371 5,475 Share Premium 10,279 10,279 10,279 Profit and loss account (15,897) (15,707) (15,823) Equity shareholders deficit (143) (57) (69) Azure Holdings plcCash Flow Statementfor the six months ended 30 June 2005 6 months ended 6 months ended 30 June 2005 30 June 2004 (unaudited) (unaudited) ‚£'000 ‚£'000 Net cash outflow from operating (13) (214)activities Financing Issue of ordinary shares - 105 Decrease in cash (13) (109)Azure Holdings plcNotes to the Interim Results 1. The interim results are unaudited and do not constitute statutory accounts within the meaning of section 240 of the Companies Act 1985. The figures for the year ended 31 December 2004 have been extracted from the statutory accounts filed with the registrar of companies on which the auditors gave an unqualified report. 2. The interim results have been prepared using the accounting policies set out in the statutory accounts for the year ended 31 December 2004. 3. The comparative figures for the unaudited interim results for the period ended 30 June 2004 are stated as announced on 29 September 2004. 4. Loss per share The earnings per share for the six months ended 30 June 2005 has beencalculated on the basis of the loss after taxation for the period of ‚£74,000(2004: ‚£229,000 ) and the weighted average number of shares in issue during theperiod of 48,317,569 (2004: 35,417,565). 5. The directors do not propose to pay a dividend for the period. 6. Copies of the interim results are available from the Company's registered office, One Great Cumberland Place, London, W1H 7AL. ENDAZURE HOLDINGS PLC
Date   Source Headline
30th Apr 20208:00 amRNSHolding(s) in Company
30th Apr 20207:00 amRNSChange of Management Team
29th Apr 20205:42 pmRNSStatement re social media reports
24th Apr 20207:00 amRNSHolding(s) in Company
23rd Apr 202011:04 amRNSHolding(s) in Company
16th Apr 20202:05 pmRNSSecond Price Monitoring Extn
16th Apr 20202:00 pmRNSPrice Monitoring Extension
14th Apr 202012:41 pmRNSResult of General Meeting & Directorate Change
14th Apr 202010:08 amRNSChange of Director
9th Apr 20202:39 pmRNSChange of Arrangements for General Meeting
1st Apr 202011:59 amRNSResult of General Meeting
1st Apr 20207:00 amRNSConditional Placing
30th Mar 20207:00 amRNSUpdate
25th Mar 20209:44 amRNSGeneral Meeting - Adjournment
16th Mar 20207:00 amRNSPosting of Circular & Notice of General Meeting
10th Mar 20207:00 amRNSPosting of Circular & Notice of General Meeting
4th Mar 20203:28 pmRNSShareholder Requisition Notice
17th Feb 20202:05 pmRNSSecond Price Monitoring Extn
17th Feb 20202:00 pmRNSPrice Monitoring Extension
17th Feb 202012:07 pmRNSResult of General Meeting & working capital update
12th Feb 20207:00 amRNSChange of Venue for General Meeting-17 Feb 2020
30th Jan 20202:00 pmRNSPosting of Circular & Notice of General Meeting
14th Jan 20207:00 amRNSUpdate - ValiSeek
6th Jan 20207:00 amRNSPlacing, Issue of Warrant & Appointment of Broker
16th Dec 20199:05 amRNSSecond Price Monitoring Extn
16th Dec 20199:00 amRNSPrice Monitoring Extension
16th Dec 20197:00 amRNSVAL201 Update
28th Nov 20197:00 amRNSUS Patent Grant re VAL201 & Metastatic Cancer
13th Nov 201911:33 amRNSHolding(s) in Company
13th Nov 20197:00 amRNSAppointment of Joint Broker
11th Nov 20193:30 pmRNSHolding(s) in Company
21st Oct 201911:47 amRNSPassing of Non-Executive Chairman
14th Oct 20191:23 pmRNSPlacing & Issue of Equity
9th Oct 20194:35 pmRNSPrice Monitoring Extension
26th Sep 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSCompany Update
10th Sep 20195:15 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSVAL201 Update
6th Aug 20197:00 amRNSCompany Update & Change of Adviser
1st Aug 20197:00 amRNSNew European patent allowance for VAL301
23rd Jul 20194:02 pmRNSHolding(s) in Company
23rd Jul 20197:00 amRNSAppointment of Joint Broker
10th Jul 20197:00 amRNSMarketing and Communications Update
9th Jul 201911:14 amRNSChange of Registered Address
4th Jul 20197:00 amRNSUpdate re VAL301
28th Jun 20191:33 pmRNSHolding(s) in Company
28th Jun 201912:31 pmRNSIssue of Equity
28th Jun 201912:03 pmRNSResult of AGM
26th Jun 201912:00 pmRNSHolding(s) in Company
26th Jun 20197:00 amRNSUS Notice of Allowance-VAL201 & Metastatic Cancer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.